Dr. Krentel is a behavioral health scientist at the Bruyère Health Research Institute and Associate Professor at the School of Epidemiology and Public Health at the University of Ottawa. Dr. Krentel has extensive research experience focusing on topics such as mass drug administration for neglected tropical diseases (NTDs), understanding the factors that motivate and sustain community drug distributors for the elimination of NTDs, and assessing the support structures to accelerate the treatment of lymphatic filariasis. Dr. Krentel has conducted such research in collaboration with organizations such as the Bill and Melinda Gates Foundation, the Task Force for Global Health, Pan American Health Organization, and others.
Dr. Krentel is a founding member of the Canadian Network for Neglected Tropical Diseases and a Senior Research Fellow for WHO Collaborating Center for Knowledge Translation and Health Technology. Dr. Krentel completed her postgraduate studies (MSc, PhD) at the London School of Hygiene and Tropical Medicine, UK.